Use of Orthodeoxia by pulse Oximetry in the detection of Hepatopulmonary Syndrome
Article Sidebar
Main Article Content
Abstract
Chronic Hepatic deficiency due to the ingestion of alcohol remains as one of the main causes of morbidity and mortality in our country. From it a variety of complications arise, one of them is the Hepatopulmonary Syndrome, which usually goes unnoticed and undiagnosed; this syndrome is distinguished by the presence of hypoxemia and pulmonary vasodilation. The gold standard to establish a diagnostic is contrast-enhanced Echocardiogram. No pathognomonic sign is known for this syndrome, which leads the present elaboration to evaluate the use of orthodeoxia by pulse oximetry as a screening test in the detection of Hepatopulmonary Syndrome cases.
Article Details
Copyright (c) 2017 Garcia CRA, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Salazar-Marcelino AE, Herrera-García JC, Toledo-Estrada J, Mendoza-Torres MA, Romero- Ogawa T. Síndrome Hepatopulmonar: Situación clínica en un hospital de tercer nivel en Puebla, Mexico. Neumólogo Cir Tórax. 2016; 75: 18-24. Ref.: https://goo.gl/41PTHu
Nacif LS, Andraus W, Pinheiro RS, Ducatti L, Haddad LB, et al. The hepatopulmonary syndrome. Arq Bras Cir Dig. 2014; 27: 145-147. Ref.: https://goo.gl/wT8WE5
Muñoz JG. Síndrome hepatopulmonar. Rev Med Cos Cen. 2014; 71: 395-401. Ref.: https://goo.gl/cHUySF
Raevens S, Geerts A, Van Satenkiste C, Verhelest X, Van Vlerberghe H, et al. Hepatopulmonary syndrome and portopulmonary hipertensión: reventar knowtedege in pathogenesis and overview of clinical assessment. Liver Int. 2015; 35: 1646-1660. Ref.: https://goo.gl/U8xc7Q
Sáenz-Gómez J, Karam- Bechara J, Jamaica-Banderas L. Síndrome hepatopulmonar como causa de hipoxemia en niños con enfermedad hepática. Bol Med Hospital Infantil Mex. 2015; 72: 124-128. Ref.: https://goo.gl/yWgbdd
Muñoz-Maya OG, Santos OM, Granda P, Vega J, Martin JI, et al. Síndrome hepatopulmonar en paciente con hipertensión portal no cirrotica. Reporte de caso. Rev Col Gastroenterol. 2012; 27: 323-326. Ref.: https://goo.gl/1XD8DL
Orozco-Delgado M, López-Cantero M, Zampe, la V, Vicente R, Galan J. Factores predicadores de mortalidad y estrategias de detección precoz de síndrome hepatopulmonar en pacientes transpalntados hepáticos. Predictors of mortality and early detection strategies for hepatopulmonary syndrome in liver transplant patients. Rev Colombia Anestesiol. 2016; 44: 311-316. Ref.: https://goo.gl/hyFDde
Lyer VN, Swanson KI, Cartín CR, Dierkhising RA, Rosen CB, et al. Hepatopulmonary syndrome: favorable outcomes ni the MELD exception Era. Hepatology jun. 2013; 57: 2427-2435. Ref.: https://goo.gl/PZXk5A
Carrillo ER, Gonzalez SJ, Serralde ZA. Síndrome Hepatopulmonar. Rev Fac Med. 2001; 44: 207-211.
Navasa M, Agusti C. Síndrome Hepatopulmonar. Asociación Española de Estudios del Higado.
Lange PA, Stoller KJ. The Hepatopulmonary Syndrome. Ann Intern Med. 1995; 122: 521-29. Ref.: https://goo.gl/6iAwuo
Grace JA, Angus PW. Hepatopulmonary syndrome: update on recent advances in phatophysiology, invetigation, and treatment. J Gastroenterol Hepatol. 2013; 28: 213-219. Ref.: https://goo.gl/bw9oYk
Rabiller A, Núñez H, Lebrec D, Tazl KA, Wartski M, et al. Prevention os gram-negative translocation reduces the severidad oh hepatopulmonary syndrome. Am J Respir Crit Care Med. 2002; 66: 514-517. Ref.: https://goo.gl/Yj5uhG
Ahad E, Amir AK, Seung KA. Pharmacologivsl treatment for hepatopulmonary syndrome. Bío Med Research International. 2013. Ref.: https://goo.gl/DbA2yB